Disse retrospektive undergruppeanalyser pegede i retning af, at relapser så vel som udtalt EDSS- progression (EDSS > 1 point eller > 0, 5 point for EDSS > = 6 i de forudgående to år) kan medvirke til at identificere patienter med aktiv sygdom.
From these retrospective subgroup analyses there was evidence to suggest that relapses as well as pronounced EDSS progression (EDSS > 1 point or > 0.5 point for EDSS > =6 in the previous two years) can help to identify patients with active disease.